arrow
M

Michael Kosicki

Lawrence Berkeley National Laboratory
H指数:15
被引数:3,572

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

3D epigenome of glial cell types in developing human cortex

发育中人类皮质胶质细胞类型的3D表观基因组

Nature
IF48.5
2026-09-020
OA
Non-coding structural variants disrupt FOXG1 transcriptional regulation in early neurodevelopment

非编码结构变异破坏早期神经发育中FOXG1转录调控

2026-06-030
OAAI
Multiomics and deep learning dissect regulatory syntax in human development

多组学和深度学习解析人类发育中的调控语法

Nature
IF48.5
2026-04-080
OAAI
Uncovering hidden enhancers through unbiased in vivo testing

通过无偏见体内测试揭示隐藏的增强子

2025-08-080
OA
In vivo mapping of mutagenesis sensitivity of human enhancers

Kosicki, M.; Zhang, B.; Hecht, V.; Pampari, A.; Cook, L.E.; Slaven, N.; Akiyama, J.A.; Plajzer-Frick, I.; Novak, C.S.; Kato, M. 人体增强子突变敏感性在体定位。Nature 2025, 643, 839–846. [Google Scholar] [CrossRef]

Nature
IF48.5
2025-06-180
PRE
Massively parallel reporter assays and mouse transgenic assays provide correlated and complementary information about neuronal enhancer activity

大规模并行报告者分析和小鼠转基因分析提供了关于神经元增强子活性的相关且互补的信息

2025-05-230
OA
A gene desert required for regulatory control of pleiotropic Shox2 expression and embryonic survival
2024-10-100
OAAI
A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders
2024-09-270
OAAI
Dynamic enhancer landscapes in human craniofacial development
2024-03-062
OAAI
Noncoding variants alter GATA2 expression in rhombomere 4 motor neurons and cause dominant hereditary congenital facial paresis
2023-06-297
OAAI
Genome-wide fetalization of enhancer architecture in heart disease
2022-09-018
OAAI